Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV002227811 | SCV002506942 | uncertain significance | Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome | 2021-04-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004738562 | SCV005358689 | uncertain significance | POGZ-related disorder | 2024-08-28 | no assertion criteria provided | clinical testing | The POGZ c.163A>G variant is predicted to result in the amino acid substitution p.Ile55Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0065% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |